Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Deficit

v3.20.2
Condensed Statements of Stockholders' Deficit - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Mar. 31, 2019 $ 988 $ 3,448,857 $ (6,844,488) $ (3,394,643)
Balance, shares at Mar. 31, 2019 9,875,000      
Stock-based compensation expense $ 600 2,601,245 2,601,845
Stock-based compensation expense, shares 6,000,000      
Issuance of common stock and warrants in connection with cancellation of consulting agreement $ 10 264,510 264,520
Issuance of common stock and warrants in connection with cancellation of consulting agreement, shares 100,000      
Issuance of common stock in connection with notes payable $ 42 320,958 321,000
Issuance of common stock in connection with notes payable, shares 421,000      
Beneficial conversion feature in connection with notes payable   27,918 27,918
Net loss     (5,026,430) (5,026,430)
Balance at Sep. 30, 2019 $ 1,640 6,663,488 (11,870,918) (5,205,790)
Balance, shares at Sep. 30, 2019 16,396,000      
Balance at Jun. 30, 2019 $ 1,605 4,634,601 (9,069,738) (4,433,532)
Balance, shares at Jun. 30, 2019 16,050,000      
Stock-based compensation expense 1,769,422 1,769,422
Issuance of common stock in connection with notes payable $ 35 259,465   259,500
Issuance of common stock in connection with notes payable, shares 346,000      
Net loss     (2,801,180) (2,801,180)
Balance at Sep. 30, 2019 $ 1,640 6,663,488 (11,870,918) (5,205,790)
Balance, shares at Sep. 30, 2019 16,396,000      
Balance at Mar. 31, 2020 $ 1,733 9,486,129 (16,448,359) (6,960,497)
Balance, shares at Mar. 31, 2020 17,324,333      
Issuance of common stock and warrants, net of fees $ 139 1,063,341 1,063,480
Issuance of common stock and warrants, net of fees, shares 1,390,000      
Issuance of common stock in satisfaction of accounts payable $ 16 121,819 121,835
Issuance of common stock in satisfaction of accounts payable, shares 162,447      
Issuance of common stock in connection with conversion of notes $ 470 4,493,153 4,493,623
Issuance of common stock in connection with conversion of notes, shares 4,706,406      
Issuance of common stock warrants 263,328 263,328
Exercise of common stock warrants $ 29 (29)
Exercise of common stock warrants, shares 291,667      
Issuance of common stock to consultants $ 31 282,078 282,109
Issuance of common stock to consultants, shares 310,010      
Stock-based compensation expense $ 400 9,049,255 9,049,655
Stock-based compensation expense, shares 4,000,000      
Issuance of common stock in connection with notes payable $ 96 930,054 930,150
Issuance of common stock in connection with notes payable, shares 955,000      
Beneficial conversion feature in connection with notes payable 618,657 618,657
Common stock repurchased and subsequently canceled $ (50) (224,950) (225,000)
Common stock repurchased and subsequently canceled, shares (500,000)      
Net loss (16,228,512) (16,228,512)
Balance at Sep. 30, 2020 $ 2,864 26,082,835 (32,676,871) (6,591,172)
Balance, shares at Sep. 30, 2020 28,639,863      
Balance at Jun. 30, 2020 $ 2,478 21,264,419 (26,910,389) (5,643,492)
Balance, shares at Jun. 30, 2020 24,777,701      
Issuance of common stock, net of fees $ 139 1,063,341 1,063,480
Issuance of common stock, net of fees, shares 1,390,000      
Issuance of common stock in connection with conversion of notes $ 234 2,341,928 2,342,162
Issuance of common stock in connection with conversion of notes, shares 2,342,163      
Issuance of common stock warrants   263,328   263,328
Stock-based compensation expense 970,432   970,432
Issuance of common stock in connection with notes payable $ 13 179,387 179,400
Issuance of common stock in connection with notes payable, shares 130,000      
Net loss     (5,766,482) (5,766,482)
Balance at Sep. 30, 2020 $ 2,864 $ 26,082,835 $ (32,676,871) $ (6,591,172)
Balance, shares at Sep. 30, 2020 28,639,863